Chronic News and Research

RSS

Tonsillectomy increases risk of pediatric obesity

Tonsillectomy is the most common major surgical procedure performed in children. Children who undergo the surgical removal of their tonsils (tonsillectomy), with or without the removal of their adenoids (adenoidectomy), are at increased risk for becoming overweight after surgery, according to new research published in the February 2011 issue of Otolaryngology - Head and Neck Surgery.

1 Feb 2011

Mayo Clinic opens new center to deliver optimal health care solutions

Mayo Clinic announced the launch of a new initiative focused on creating new and improved approaches to delivering health care. The Center for the Science of Health Care Delivery will design, implement, measure and disseminate high-value health care best practices with initial focus areas that include wellness and the prediction, prevention, and management of chronic diseases.

1 Feb 2011

MAP Pharmaceuticals, Allergan collaborate for LEVADEX to treat acute migraine in adults

Allergan, and MAP Pharmaceuticals, today announced a collaboration within the United States for LEVADEX, a self-administered, orally inhaled therapy that has completed Phase III clinical development for the treatment of acute migraine in adults.

31 Jan 2011

Nutritionist offers tips to keep on track with weight loss and health goals

At a time when many people are working to lose weight and get healthier, more than half of Texans admit to lying to family or doctors about their health and fitness habits such as nutrition and amount of exercise, according to the True Results Health Honesty Survey. Forty-six percent are not honest with family members and 32 percent admit to lying to doctors.

31 Jan 2011

KCI announces agreement to license Wright Medical Group's GRAFTJACKET for wound care

Kinetic Concepts, announced today an agreement to license Wright Medical Group, GRAFTJACKET brand for use in marketing the LifeCell™ acellular human dermal-based regenerative tissue matrix for wound applications such as diabetic foot ulcers and venous stasis ulcers.

31 Jan 2011

Scientists to commence new DNA vaccine trial for use in patients with leukemia

A new cancer treatment which strengthens a patient's immune system and enables them to fight the disease more effectively is being trialled on patients for the first time in the UK. The treatment will use a new DNA vaccine, developed by scientists from the University of Southampton, which will treat a selected group of volunteers who have either chronic or acute myeloid leukaemia - two forms of bone marrow and blood cancer.

31 Jan 2011

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

Inovio Pharmaceuticals, a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the regulatory approval of a Phase 2 clinical trial to treat leukemia utilizing Inovio's new ELGEN 1000 automated vaccine delivery device.

31 Jan 2011

New nicotine addiction mechanism revealed

A new discovery has shown why some people cannot give up tobacco and may lead to new anti-smoking treatments. The researchers have found a brain pathway which when defective leads to an uncontrollable desire to smoke. This is a “sub-unit” of a receptor protein sensitive to nicotine.

31 Jan 2011

$61 million anti-tobacco campaign launched to prevent lung cancer

The Australian Federal Government is backing a $61 million advertising campaign to stop smoking. This is the nation’s biggest anti-tobacco campaign. The message is graphic and simple: every cigarette brings cancer closer. Health groups have backed the campaign but advertising industry experts say the public has become increasingly immune to scare campaigns.

31 Jan 2011

Omega-3 deficieny may play a role in neuropsychiatric disorders: Study

Researchers from Inserm and INRA and their collaborators in Spain collaboration, have studied mice fed on a diet low in omega-3 fatty acid. They discovered that reduced levels of omega-3 had deleterious consequences on synaptic functions and emotional behaviours.

30 Jan 2011

PPTA offers new DVD on plasma donation

Anyone curious about what to expect as a plasma donor and how plasma contributes to lifesaving medicines can now learn about the process thanks to a new DVD from the Plasma Protein Therapeutics Association.

29 Jan 2011

Phase III study shows tapentadol ER relieves chronic pain associated with DPN

New research has been published indicating that patients suffering from a painful complication of diabetes may experience a significant improvement in their pain as measured by a pain intensity scale when using an investigational pain medication.

29 Jan 2011

Research sheds light on role of helping in addiction recovery

Participating in community service activities and helping others is not just good for the soul; it has a healing effect that helps alcoholics and other addicts become and stay sober, a researcher from Case Western Reserve University School of Medicine reports.

29 Jan 2011

Etanercept can restore responsiveness to pain-relieving effects of morphine: Study

A drug called etanercept can restore responsiveness to the pain-relieving effects of morphine in rats that have developed morphine tolerance, reports a study in the February issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

29 Jan 2011

BGU, PTT sign R&D collaboration agreement for commercial development of green algae strain

Ben-Gurion University of the Negev and the PTT Chemical Public Company Ltd. in Thailand have signed a research and development collaboration agreement for commercial development of BGU's proprietary green algae strain.

29 Jan 2011

Study explores why African-American men don't visit doctor more often

A majority of African American men said they do not go to the doctor because visits are stressful and physicians don't give adequate information on how to make prescribed behavior or lifestyle changes, a new University of Michigan study shows.

29 Jan 2011

FDA approves Arteriocyte's Magellan MAR01 technology for Phase I trial to treat CLI

Arteriocyte, a leading clinical stage biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts that develops proprietary stem cell and tissue engineering based therapies, announced today approval from the Food and Drug Administration to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Critical Limb Ischemia.

29 Jan 2011

Spanish language soap opera to focus on obesity crisis

New episodes of a critically acclaimed, locally-produced Spanish language soap opera will focus on the obesity crisis in hopes of helping viewers better understand what causes obesity and how they can live healthier lives.

29 Jan 2011

Exposure to infections in early childhood can protect child from eczema later in life: Study

Exposure to worm infections in the womb may protect a newborn infant from developing eczema, a study funded by the Wellcome Trust suggests. A large trial in Uganda showed that treating a pregnant woman for worm infections increased her child's chances of developing the allergic skin disease.

29 Jan 2011

European Commission to implement SUNRAY-project to tackle malnutrition in Africa

The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.

28 Jan 2011

Chronic News and Research

Tonsillectomy increases risk of pediatric obesity

Mayo Clinic opens new center to deliver optimal health care solutions

MAP Pharmaceuticals, Allergan collaborate for LEVADEX to treat acute migraine in adults

Nutritionist offers tips to keep on track with weight loss and health goals

KCI announces agreement to license Wright Medical Group's GRAFTJACKET for wound care

Scientists to commence new DNA vaccine trial for use in patients with leukemia

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

New nicotine addiction mechanism revealed

$61 million anti-tobacco campaign launched to prevent lung cancer

Omega-3 deficieny may play a role in neuropsychiatric disorders: Study

PPTA offers new DVD on plasma donation

Phase III study shows tapentadol ER relieves chronic pain associated with DPN

Research sheds light on role of helping in addiction recovery

Etanercept can restore responsiveness to pain-relieving effects of morphine: Study

BGU, PTT sign R&D collaboration agreement for commercial development of green algae strain

Study explores why African-American men don't visit doctor more often

FDA approves Arteriocyte's Magellan MAR01 technology for Phase I trial to treat CLI

Spanish language soap opera to focus on obesity crisis

Exposure to infections in early childhood can protect child from eczema later in life: Study

European Commission to implement SUNRAY-project to tackle malnutrition in Africa

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News